350
Participants
Start Date
November 30, 2022
Primary Completion Date
November 30, 2028
Study Completion Date
November 30, 2028
HDL2
to perform additional blood samples during acute phase of complications (realized between Day 1 and Day 3) in SCD patients hospitalized for vasoocclusive crisis or priapism.
RECRUITING
Unité Transversale de la Drépanocytose, Pointe à Pitre
NOT_YET_RECRUITING
Centre de Référence de la Drépanocytose, Le Lamentin
Direction Générale de l'Offre de Soins
OTHER_GOV
Centre Hospitalier Universitaire de la Guadeloupe
OTHER